Natural history of autosomal dominant polycystic kidney disease.

Diagnosis and management of polycystic liver disease. Nat Rev Gastroenterol Hepatol (2013) 1.46

Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.10

Uric acid changes in urine and plasma: an effective tool in screening for purine inborn errors of metabolism and other pathological conditions. J Inherit Metab Dis (2007) 0.83

Ruptured sinus of a Valsalva aneurysm associated with autosomal-dominant polycystic kidney disease in an elderly patient: report of a case. Surg Today (2000) 0.77

Ruptured sinus of Valsalva aneurysm in a patient with autosomal dominant polycystic kidney disease. West J Med (1996) 0.77

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease. BMC Nephrol (2012) 0.76

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56

The spectrum of rhabdomyolysis. Medicine (Baltimore) (1982) 6.15

The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.82

Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med (1992) 2.34

Linkage heterogeneity of autosomal dominant polycystic kidney disease. N Engl J Med (1988) 2.16

Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med (1978) 2.13

Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int (2001) 2.09

Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 1.81

Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics (1993) 1.77

Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis (1998) 1.64

Nonoliguric acute renal failure. N Engl J Med (1977) 1.64

Unrecognized adult salicylate intoxication. Ann Intern Med (1976) 1.63

Syndromes of toluene sniffing in adults. Ann Intern Med (1981) 1.63

Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1994) 1.61

Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol (1997) 1.52

Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. Ann Intern Med (1991) 1.44

Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med (1988) 1.40

Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant. J Ultrasound Med (1987) 1.28

The fall of the serum anion gap. Arch Intern Med (1990) 1.28

Polycystic kidney disease: prospective analysis of nonazotemic patients and family members. Ann Intern Med (1984) 1.24

Organic acids in ethylene glycol intoxication. Ann Intern Med (1986) 1.23

Diagnostic importance of an increased serum anion gap. N Engl J Med (1980) 1.18

Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 1.17

Percutaneous cyst puncture in the treatment of cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1990) 1.13

Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1994) 1.13

Renal cell carcinoma: unusual systemic manifestations. Medicine (Baltimore) (1976) 1.11

Disorders associated with an altered anion gap. Kidney Int (1985) 1.10

Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia. J Cell Physiol (1992) 1.05

Hereditary and acquired cystic disease of the kidney. Kidney Int (1994) 1.05

Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1993) 1.01

Renal asymmetry in children with autosomal dominant polycystic kidney disease. Am J Kidney Dis (1999) 1.01

Tubulointerstitial and glomerular nephritis associated with rifampin. Report of a case. JAMA (1976) 0.99

The spectrum of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol (1994) 0.99

A new method for studying human polycystic kidney disease epithelia in culture. Kidney Int (1986) 0.98

Is there evidence for anticipation in autosomal-dominant polycystic kidney disease? Kidney Int (1994) 0.98

Spironolactone-induced hyperchloremic acidosis in cirrhosis. Ann Intern Med (1979) 0.97

Hypertension in autosomal dominant polycystic kidney disease. Kidney Int (1988) 0.94

Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. Am J Med Genet (1990) 0.94

Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease. Am J Nephrol (2001) 0.93

The role of alcohol in new-onset atrial fibrillation. Arch Intern Med (1983) 0.92

Toluene abuse during pregnancy: obstetric complications and perinatal outcomes. Obstet Gynecol (1991) 0.89

Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. Am J Kidney Dis (2001) 0.89

Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease. Am J Kidney Dis (1999) 0.89

Psychogenic adipsia in a patient with psychotic depression. Am J Kidney Dis (1990) 0.88

Severe acid-base abnormalities associated with cocaine abuse. J Emerg Med (1990) 0.87

Hypertension in autosomal dominant polycystic kidney disease. Kidney Int Suppl (1997) 0.87

Acid-base disturbances in the salicylate-intoxicated adult. Arch Intern Med (1978) 0.87

Comparison of hospitalization between nursing home and community residents. J Am Geriatr Soc (1985) 0.86

Polycystic kidney disease: clues to pathogenesis. Kidney Int (1991) 0.85

Progress in blood pressure control in autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 0.85

Marked elevations of serum alkaline phosphatase in patients with AIDS. J Acquir Immune Defic Syndr (1991) 0.82

A peer approach to high risk youth. J Adolesc Health (1997) 0.82

Denver Health: initiatives for survival. Health Aff (Millwood) (1997) 0.82

Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates. Am J Med (1990) 0.81

Concepts and controversies in salicylate toxicity. Emerg Med Clin North Am (1994) 0.81

Urinary chloride concentration in acute renal failure. Miner Electrolyte Metab (1984) 0.81

Insurance for autosomal dominant polycystic kidney disease patients prior to end-stage renal disease. Am J Kidney Dis (1996) 0.79

Fanconi's syndrome and distal renal tubular acidosis after glue sniffing. Ann Intern Med (1980) 0.78

Renal manifestations: complication management and long-term outcome of autosomal dominant polycystic kidney disease. Semin Nephrol (1991) 0.77

Von Hippel-Lindau disease masquerading as autosomal dominant polycystic kidney disease. Am J Kidney Dis (2001) 0.77

Frequency of ovarian cysts in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (1999) 0.77

Nephrotoxicity following single dose mithramycin therapy. Am J Nephrol (1983) 0.76

CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2000) 0.76

Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen. Am J Kidney Dis (1993) 0.76

Improving identification of and intervention for alcoholism. West J Med (1995) 0.75

Exclusion of autosomal dominant polycystic kidney disease type II (ADPKD2) from 160 cM of chromosome 1. J Med Genet (1990) 0.75

Genetic studies in a black family with autosomal dominant polycystic kidney disease and sickle-cell trait. Nephron (1996) 0.75

Futile care: prevention and process: educating patients about advance directives is crucial. J Crit Illn (1994) 0.75

Intra- and extracellular proteins in human normal and polycystic kidney epithelial cells. Kidney Int (1990) 0.75

Furosemide-induced reduction in ionized calcium in hypoparathyroid patients. Ann Intern Med (1977) 0.75

Prevention of hypercalcemia-induced renal concentrating defect and tissue calcium accumulation. Am J Physiol (1986) 0.75

Genetic linkage studies of autosomal dominant polycystic kidney disease: search for the second gene in a large Sicilian family. Hum Genet (1991) 0.75